<PAGE> 1
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON JANUARY 28, 1998
Registration No. 333-23383
- -------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
- -------------------------------------------------------------------------------
POST EFFECTIVE AMENDMENT NO. 1
TO
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
- -------------------------------------------------------------------------------
JONES MEDICAL INDUSTRIES, INC.
(Exact name of Registrant as specified in its charter)
DELAWARE 43-1229854
(State or other jurisdiction (I.R.S. Employer Identification
of incorporation or organization) Number)
1945 Craig Road, St. Louis, MO 63146 (314) 576-6100
(Address, including zip code, and telephone number, including area code, of
Registrant's principal executive offices)
DENNIS M. JONES
Jones Medical Industries, Inc.
1945 Craig Road
St. Louis, MO 63146
(314) 576-6100
(Name, address, including zip code, and telephone number, including area code,
of agent for service)
With copies of communications to:
CHARLES E. H. LUEDDE, ESQ.
Greensfelder, Hemker & Gale, P.C.
10 South Broadway, Suite 2000
St. Louis, Missouri 63102
314-241-9090
-------------------
- -------------------------------------------------------------------------------
<PAGE> 2
This Post-Effective Amendment No. 1 to the Registration Statement on
Form S-3 (File No. 333-23383) filed by Jones Medical Industries Inc. (the
"Company") which was declared effective on April 11, 1997, is filed to indicate
the completion of the offering and sale contemplated thereby.
The Company is advised by the several Selling Shareholders named in
such Registration Statement that offers and sales of an aggregate of 95,985
shares (including 5,360 shares sold by donees of the Selling Shareholders)
included in such Registration Statement were concluded prior to December 31,
1997.
Under the terms of the reorganization agreement among the Company,
Abana Pharmaceuticals, Inc. and the Selling Shareholders, the offer and sale
transactions contemplated by the Registration Statement and by the related
Prospectus dated April 11, 1997, were complete as of December 31, 1997 and no
further use or delivery of such Prospectus in connection with the offer and
sale of shares by or on behalf of the Selling Shareholders is authorized or
permitted. As of December 31, 1997 (the first anniversary of the closing of
the transactions contemplated by such reorganization agreement), Rule 144
became available to the Selling Shareholders. Accordingly, 195,265 of the
291,250 shares included in the Registration Statement may be deemed
"de-registered" for purposes of the Securities Act of 1933.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
Registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form S-3 and has duly caused this
Registration Statement to be signed on its behalf by the undersigned, thereunto
duly authorized in the County of St. Louis, State of Missouri, on the 28th day
of January, 1998.
JONES MEDICAL INDUSTRIES, INC.
By: /s/Dennis M. Jones
---------------------------
Dennis M. Jones, President
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed below by the following persons in the
capacities indicated on January 28, 1998:
SIGNATURES TITLE
<TABLE>
<S> <C>
/s/ Dennis M. Jones Chairman of the Board, President, Chief Executive
---------------------------------- Officer and Director
Dennis M. Jones, President
/s/ Judith A. Jones Principal Financial Officer, Executive Vice President,
----------------------------------- Secretary, Treasurer and Director
Judith A. Jones
</TABLE>
2
<PAGE> 3
<TABLE>
<S> <C>
/s/ Michael T. Bramblett Executive Vice President and Director
--------------------------------
Michael T. Bramblett
/s/ Edward A. Chod Director
---------------------------------
Edward A. Chod
/s/ G. Andrew Franz Senior Vice President - Operations -
---------------------------------- Pharmaceuticals and Director
G. Andrew Franz
/s/ David A. McLaughlin Senior Vice President - Operations -
------------------------------- Nutritionals and Director
David A. McLaughlin
-------------------------------------------- Director
Stanley Lopata
-------------------------------------------- Director
L. John Polite, Jr.
-------------------------------------------- Director
Thomas F. Patton
</TABLE>
3
